Andreas G. Bader

2 ta ish

Mirna Therapeutics (United States)

1. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

   David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad +20

   MaqolaOAOchiq kirish20206 iqtibos

   ABIABI:AkademIndex/2026.other.213689

2. The<i>let-7</i>microRNA reduces tumor growth in mouse models of lung cancer

   Aurora Esquela‐Kerscher, Phong Trang, Jason F. Wiggins +7

   Maqola20082 iqtibos

   ABIABI:AkademIndex/2026.other.304808